Given PARP-1’s critical role in DNA damage repair, using PARP-1 inhibitors to enhance the efficacy of anti-cancer treatments could increase tumor cell sensitivity to radiotherapy or chemotherapy (Underhill et al., 2011). The gene discussed is PARP1; the disease is cancer.